Noticing Weight Gain? It Might Be Your Diabetes Medication!

Published: Apr 12, 2024

Weight gain is a common issue with diabetes medications like thiazolidinediones. Here's why it's happening and what you can do about it.
Contents

Why Weight Gain Happens

Weight gain with thiazolidinediones is partly due to fluid retention and increased fat storage. These medications can cause the body to hold onto more water, leading to an increase in weight. They also affect fat cells, promoting weight gain over time.

Managing the Weight Gain

If you're gaining weight on thiazolidinediones, talk to your doctor about adjusting the dose or trying a different medication. Monitoring your diet and exercise can help manage weight gain. Remember, being proactive can help you stay healthy and avoid complications.
Weight gain is a potential side effect of diabetes medications, including thiazolidinediones, often due to fluid retention and fat storage.

Long-Term Implications

Over time, weight gain can lead to other health issues, including increased risk of heart disease. It's essential to work with your healthcare provider to manage weight effectively. Regular check-ups can help catch any issues early and keep your health on track.

Frequently Asked Questions

Thiazolidinediones can cause fluid retention and increased fat storage.

Talk to your doctor about dose adjustments and focus on diet and exercise.

It can lead to other issues like heart disease, so it's important to manage it.

Yes, discuss alternative medications with your healthcare provider.

Yes, regular check-ups can help monitor your weight and overall health.

Key Takeaways

Managing weight gain from diabetes medications is crucial for long-term health.
For personalized advice on managing weight gain, consult with Doctronic today.

Related Articles

References

  1. Basu A, Jensen MD, McCann F, et al. Effects of pioglitazone versus glipizide on body fat distribution, body water content, and hemodynamics in type 2 diabetes. Diabetes Care 2006; 29:510.
  2. Bogacka I, Xie H, Bray GA, Smith SR. The effect of pioglitazone on peroxisome proliferator-activated receptor-gamma target genes related to lipid storage in vivo. Diabetes Care 2004; 27:1660.

This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic. Always discuss health information with your healthcare provider.

AI Doctor Visit Required

Appointments available 24/7

😀 😀 😀
stethoscope

Top licensed doctors

Available in all 50 states

dossier

Full service care

Prescriptions, referrals & treatment

check

No insurance needed

All notes available in Doctronic

15-min consultation. No hidden costs.

AI Doctor Visit Required
Close icon

Please Chat With Our AI Doctor First

Our AI doctor assessment helps our human doctors prepare for your video visit and provide better care

Lifebuoy

For safety reasons we have been forced to end this consultation.

If you believe this is a medical emergency please call 911 or your local emergency services immediately.

If you are experiencing emotional distress, please call the the Suicide & Crisis Lifeline at 988 or your local crisis services immediately.

Contact us

You can also email us at help@doctronic.ai

We aim to reply within 5-7 days

How likely are you to recommend Doctronic to friends or family?
Not likely at all Extremely likely